Neoaska Pharma Private Limited

Neoaska Pharma Private Limited - pharma in Seri Lingampally, Telangana, India. FY 2026 financials and compliance.
CIN U74999TG2017PTC119969 Incorporated 10 October 2017 ROC Hyderabad HQ Seri Lingampally, Telangana, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹3.17 Lakh
▼ 53.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹150 Cr
Registered with MCA
Paid-up capital
₹23.12 Cr
Issued & subscribed
Open charges
None
Satisfied ₹18.96 Cr
Company age
9 yrs
Est. 2017
Employees · EPFO
30
Latest available

About Neoaska Pharma Private Limited

Data last updated: 24 February 2026

Neoaska Pharma Private Limited is a private limited company based in Seri Lingampally, Telangana, India, a subsidiary of Omnicare Drugs India Private Limited. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 10 October 2017, the company has been in operation for over 9 years.

Registered with ROC Hyderabad under CIN U74999TG2017PTC119969.

Capital: an authorised share capital of ₹150 Cr and a paid-up capital of ₹23.12 Cr. Formerly known as Neo Aska Pharma Private Limited and Neumedica Life Sciences Private Limited. It is led by directors Nagaraja Rathan Yancharla and Pakanati Venkata Raghava Reddy.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Seri Lingampally, Telangana.

As per the financials filed for FY 2025, the company reported a revenue of ₹3.17 Lakh, a decline of 53% compared to the previous year.

The company has a workforce of approximately 30 employees as per the latest available data. It operates as a subsidiary of Omnicare Drugs India Private Limited.

As per MCA filings, the company has satisfied charges of ₹18.96 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website tatvalegal.com.

Company Details of Neoaska Pharma Private Limited
CIN U74999TG2017PTC119969
Registration Number 119969
Incorporation Date 10 October 2017
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Omnicare Drugs India Private Limited
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    Door No 1 – 66/1/Ceo/1/Ph Plot No 1 Ceo Enclave, Sy No. 136/2 And 136/4 Gachibowli Hyderabad, Seri Lingampally, Telangana, India – 500032
  • Industry
    Pharma, Drug Formulation & Development
Company report
Neoaska Pharma Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Neoaska Pharma Private Limited report

Financials, compliance, directors, charges, ownership and filings for Neoaska Pharma Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Name History of Neoaska Pharma Private Limited

Neoaska Pharma Private Limited has undergone 3 name changes throughout its history. The company was previously known as Neo Aska Pharma Private Limited, Neumedica Life Sciences Private Limited, and Omnicare Aska Pharma Private Limited. The current legal name is Neoaska Pharma Private Limited, reflecting the company's evolution and rebranding over time.

Company Name Status
Neoaska Pharma Private Limited Current
Neo Aska Pharma Private Limited Previous
Neumedica Life Sciences Private Limited Previous
Omnicare Aska Pharma Private Limited Previous

Auditor Details of Neoaska Pharma Private Limited

Neoaska Pharma Private Limited is audited by M V NARAYANA REDDY & CO for the financial year 2019. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
M V NARAYANA REDDY & CO Locked Locked Locked
Premium access

Complete auditor history for Neoaska Pharma Private Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Neoaska Pharma Private Limited

Neoaska Pharma Private Limited is currently managed by 2 directors, with 9 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Nagaraja Rathan Yancharla Director 13 Jul 2023 3 Years 1 Months Current
Pakanati Venkata Raghava Reddy Additional Director 01 Dec 2023 2 Years 8 Months Current

Financials of Neoaska Pharma Private Limited FY 2025 filings available

Neoaska Pharma Private Limited reported revenue of ₹3.17 Lakh (down 53.00% YoY) for FY 2025.

Revenue · FY 2025
₹3.17 Lakh ▼ 53.00%
Premium access

Ten-year financial statements for Neoaska Pharma Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Neoaska Pharma Private Limited

Premium access

Shareholding and ownership data for Neoaska Pharma Private Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Neoaska Pharma Private Limited

Open charges
₹0
Satisfied charges
₹18.96 Cr
Breakdown by lending institutions
Others₹18.96 Cr
Latest charge details
DateLenderAmountStatus
01 Oct 2019 Others ₹18.96 Cr Satisfied

Total charge records: 1 View all charges

Employees and EPFO Compliance at Neoaska Pharma Private Limited

Neoaska Pharma Private Limited has a workforce of 30 employees as of Apr 07, 2024.

Employee count
30
Active EPFO establishments
1
Employee growth
87.5%
Premium access

Employee and EPFO history for Neoaska Pharma Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Neoaska Pharma Private Limited

Premium access

GST registrations and filing compliance for Neoaska Pharma Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Neoaska Pharma Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Neoaska Pharma Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Neoaska Pharma Private Limited

Premium access

MSME payment history for Neoaska Pharma Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Neoaska Pharma Private Limited

Premium access

Corporate group structure for Neoaska Pharma Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Neoaska Pharma Private Limited

Premium access

MCA filings and documents for Neoaska Pharma Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Neoaska Pharma Private Limited

Activity
30 Sep 2025
Neoaska Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Neoaska Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Directors
01 Dec 2023
Pakanati Venkata Raghava Reddy was appointed as a Additional Director on 01 Dec 2023 & has been associated with this company since 2 years 8 months.
Charges
18 Aug 2023
A charge registered on 01 Oct 2019 via Charge ID 100297367 with Others was fully satisfied on 18 Aug 2023.
Directors
13 Jul 2023
Nagaraja Rathan Yancharla was appointed as a Director on 13 Jul 2023 & has been associated with this company since 3 years 1 month.
Charges
18 May 2022
A charge with Others of Rs. 18.96 Cr registered on 01 Oct 2019 with Charge ID 100297367 was modified on 18 May 2022.

Frequently Asked Questions about Neoaska Pharma Private Limited

Neoaska Pharma Private Limited is an active private limited company in the pharma sector based in Seri Lingampally, Telangana, India. It was incorporated on 10 October 2017 (9+ years old) and is registered under CIN U74999TG2017PTC119969. The company has 30 employees.

Neoaska Pharma Private Limited reported revenue of ₹3.17 Lakh for FY 2025 (down 53.00% YoY).

The current directors of Neoaska Pharma Private Limited are:

The primary industry of Neoaska Pharma Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Neoaska Pharma Private Limited can be reached at the registered office: Door No 1 – 661Ceo1Ph Plot No 1 Ceo Enclave, Sy No. 1362 And 1364 Gachibowli Hyderabad, Seri Lingampally, Telangana, India – 500032, or through the website tatvalegal.com.

The authorised capital is ₹150 Cr, and the paid-up capital is ₹23.12 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available